San Jose, CA, October 16, 2008 --(PR.com
)-- AnaSpec, a worldwide provider of integrated proteomics solutions, published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. The article, written by AnaSpec employees Cecilia Po and Vera Rakhmanova, Ph.D., offers a general overview of FRET (Fluorescence Resonance Energy Transfer) technology. It also highlights some of the applications and methodologies of FRET-based assays, using several of AnaSpec’s own FRET substrates and assay kits as examples.
The article is available online at: http://www.photonics.com/content/bio/2008/August/features/93090.aspx
About AnaSpec, Inc.
AnaSpec, Inc. is a leading provider of integrated proteomics solutions™ for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry.
Visit www.anaspec.com for more information.
About Biophotonics International
Biophotonics International presents the latest global developments and techniques in the photonics industry to those in the medical and biotechnology fields. Photonics, the science of light, has a history of success in solving clinical and research problems in diverse applications through such products and techniques as spectroscopy, lasers, microscopy, imaging and fiber optics.
Visit www.photonics.com for more information